Merck (MRK) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Merck Revenue Highlights

Latest Revenue (Y)

$64.17B

Latest Revenue (Q)

$16.66B

Main Segment (Y)

Pharmaceutical segment

Main Geography (Y)

UNITED STATES

Merck Revenue by Period

Merck Revenue by Year

Date	Revenue	Change
2024-12-31	$64.17B	6.74%
2023-12-31	$60.12B	1.40%
2022-12-31	$59.28B	21.72%
2021-12-31	$48.70B	17.31%
2020-12-31	$41.52B	-11.36%
2019-12-31	$46.84B	10.75%
2018-12-31	$42.29B	5.41%
2017-12-31	$40.12B	0.79%
2016-12-31	$39.81B	0.78%
2015-12-31	$39.50B	-6.48%
2014-12-31	$42.24B	-4.08%
2013-12-31	$44.03B	-6.84%
2012-12-31	$47.27B	-1.62%
2011-12-31	$48.05B	4.48%
2010-12-31	$45.99B	67.66%
2009-12-31	$27.43B	15.00%
2008-12-31	$23.85B	-1.44%
2007-12-31	$24.20B	6.90%
2006-12-31	$22.64B	2.84%
2005-12-31	$22.01B	-4.04%
2004-12-31	$22.94B	2.01%
2003-12-31	$22.49B	-56.58%
2002-12-31	$51.79B	8.54%
2001-12-31	$47.72B	18.22%
2000-12-31	$40.36B	23.38%
1999-12-31	$32.71B	21.62%
1998-12-31	$26.90B	13.80%
1997-12-31	$23.64B	19.21%
1996-12-31	$19.83B	18.87%
1995-12-31	$16.68B	11.43%
1994-12-31	$14.97B	42.59%
1993-12-31	$10.50B	-

Merck generated $64.17B in revenue during NA 2024, up 6.74% compared to the previous quarter, and up 136.99% compared to the same period a year ago.

Merck Revenue by Quarter

Date	Revenue	Change
2024-09-30	$16.66B	3.10%
2024-06-30	$16.16B	2.42%
2024-03-31	$15.78B	7.83%
2023-12-31	$14.63B	-8.34%
2023-09-30	$15.96B	6.17%
2023-06-30	$15.04B	3.78%
2023-03-31	$14.49B	4.75%
2022-12-31	$13.83B	-7.55%
2022-09-30	$14.96B	2.51%
2022-06-30	$14.59B	-8.23%
2022-03-31	$15.90B	17.60%
2021-12-31	$13.52B	2.79%
2021-09-30	$13.15B	15.37%
2021-06-30	$11.40B	7.29%
2021-03-31	$10.63B	-15.09%
2020-12-31	$12.52B	14.51%
2020-09-30	$10.93B	16.85%
2020-06-30	$9.35B	-22.43%
2020-03-31	$12.06B	1.59%
2019-12-31	$11.87B	-4.27%
2019-09-30	$12.40B	5.42%
2019-06-30	$11.76B	8.73%
2019-03-31	$10.82B	-1.65%
2018-12-31	$11.00B	1.89%
2018-09-30	$10.79B	3.14%
2018-06-30	$10.46B	4.26%
2018-03-31	$10.04B	-3.80%
2017-12-31	$10.43B	1.05%
2017-09-30	$10.32B	3.98%
2017-06-30	$9.93B	5.26%
2017-03-31	$9.43B	-6.73%
2016-12-31	$10.12B	-4.00%
2016-09-30	$10.54B	7.03%
2016-06-30	$9.84B	5.71%
2016-03-31	$9.31B	-8.84%
2015-12-31	$10.21B	1.41%
2015-09-30	$10.07B	2.94%
2015-06-30	$9.79B	3.82%
2015-03-31	$9.43B	-10.08%
2014-12-31	$10.48B	-0.71%
2014-09-30	$10.56B	-3.45%
2014-06-30	$10.93B	6.53%
2014-03-31	$10.26B	-9.33%
2013-12-31	$11.32B	2.61%
2013-09-30	$11.03B	0.20%
2013-06-30	$11.01B	3.18%
2013-03-31	$10.67B	-9.08%
2012-12-31	$11.74B	2.17%
2012-09-30	$11.49B	-6.69%
2012-06-30	$12.31B	4.94%
2012-03-31	$11.73B	-4.58%
2011-12-31	$12.29B	2.26%
2011-09-30	$12.02B	-1.06%
2011-06-30	$12.15B	4.93%
2011-03-31	$11.58B	-4.25%
2010-12-31	$12.09B	8.71%
2010-09-30	$11.13B	-1.95%
2010-06-30	$11.35B	-0.66%
2010-03-31	$11.42B	13.16%
2009-12-31	$10.09B	66.84%
2009-09-30	$6.05B	2.54%
2009-06-30	$5.90B	9.56%
2009-03-31	$5.39B	-10.73%
2008-12-31	$6.03B	1.49%
2008-09-30	$5.94B	-1.78%
2008-06-30	$6.05B	3.95%
2008-03-31	$5.82B	-6.74%
2007-12-31	$6.24B	-

Merck generated $16.66B in revenue during Q3 2024, up 3.10% compared to the previous quarter, and up 110.79% compared to the same period a year ago.

Merck Revenue Breakdown

Merck Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21
Pharmaceutical segment	$57.40B	$52.01B	-	-
Animal Health segment	$5.88B	$5.55B	-	-
Animal Health	-	$5.63B	-	-
Pharmaceutical	-	$53.58B	-	-
Other	-	$907.00M	-	-
Other Segments	-	-	-	-

Merck's latest annual revenue breakdown by segment (product or service), as of Dec 24: Pharmaceutical segment (90.71%), and Animal Health segment (9.29%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Animal Health segment	$1.40B	$1.49B	$1.48B	$1.51B	$1.40B	$1.46B	$1.49B	$1.23B	$1.37B	$1.47B	$1.48B	$1.26B	$1.42B	$1.47B	$1.42B	$1.17B	$1.22B	$1.10B	$1.21B	$1.12B
Pharmaceutical segment	$14.04B	$14.94B	$14.41B	$14.01B	$14.26B	$13.46B	$12.72B	$12.18B	$12.96B	$12.76B	$14.11B	$12.04B	$11.50B	$9.98B	$10.68B	$11.37B	$11.32B	$9.68B	$10.65B	$10.53B
Other Segments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$23.00M	$42.00M	-

Merck's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Pharmaceutical segment (90.95%), and Animal Health segment (9.05%).

Merck Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21
EMEA	$14.04B	$14.49B	-	-
Asia Pacific	$11.83B	$3.23B	$3.61B	$2.41B
Latin America	$3.46B	$3.09B	$2.58B	$2.21B
UNITED STATES	$32.28B	$27.21B	-	-
China	-	$6.80B	-	-
Other	-	$2.10B	-	-
Europe, Middle East and Africa	-	$13.25B	-	-
United States	-	$28.48B	-	-
Japan	-	$3.16B	-	-
Other Countries	-	-	$1.22B	-
JAPAN	-	-	$2.73B	-
CHINA	-	-	$4.38B	-

Merck's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (52.39%), EMEA (22.79%), Asia Pacific (19.20%), and Latin America (5.61%).

Quarterly Revenue by Country

Country	Dec 24	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Asia Pacific	$2.49B	$2.78B	$3.25B	$3.32B	$781.00M	$848.00M	$846.00M	$822.00M	$854.00M	$1.01B	$930.00M	$625.00M	$613.00M	$594.00M	$751.00M	$735.00M	$735.00M	$666.00M	$728.00M	$726.00M
EMEA	$3.38B	$3.58B	$3.52B	$3.56B	$3.33B	$3.35B	$3.30B	$3.27B	$3.29B	$3.58B	$4.36B	$3.43B	$3.34B	$3.33B	$3.73B	$3.54B	$3.45B	$3.07B	$3.53B	$3.25B
UNITED STATES	$8.19B	$8.74B	$7.88B	$7.48B	$7.71B	$7.02B	$6.66B	$6.28B	$7.32B	$6.24B	$7.34B	$6.26B	$6.28B	$5.10B	$5.14B	$5.63B	$5.63B	$4.63B	$5.14B	$5.14B
Latin America	$869.00M	$936.00M	$858.00M	$796.00M	$895.00M	$742.00M	$661.00M	$649.00M	$684.00M	$642.00M	$607.00M	$575.00M	$599.00M	$532.00M	$569.00M	$604.00M	$604.00M	$510.00M	$556.00M	$580.00M
CHINA	-	-	-	$1.77B	$1.69B	$1.91B	$1.72B	$1.23B	$1.44B	$1.37B	$1.14B	$1.37B	$1.31B	$975.00M	$927.00M	$909.00M	$1.02B	$834.00M	$864.00M	$784.00M
Other Countries	-	-	-	$621.00M	$469.00M	$491.00M	$545.00M	$728.00M	$698.00M	$637.00M	$534.00M	$462.00M	$379.00M	$207.00M	$238.00M	$225.00M	$289.00M	$290.00M	$427.00M	$437.00M
JAPAN	-	-	-	$821.00M	$1.08B	$675.00M	$758.00M	$853.00M	$673.00M	$1.11B	$989.00M	$797.00M	$638.00M	$661.00M	$730.00M	$870.00M	$828.00M	$867.00M	$811.00M	$944.00M

Merck's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (54.87%), EMEA (22.65%), Asia Pacific (16.66%), and Latin America (5.82%).

Merck Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
MRK	Merck	$64.17B	$16.66B
PFE	Pfizer	$63.63B	$17.70B
JNJ	Johnson & Johnson	$61.35B	$22.47B
BMY	Bristol-Myers Squibb	$48.30B	$11.89B
LLY	Eli Lilly and	$45.04B	$11.44B
AMGN	Amgen	$33.42B	$8.50B
GILD	Gilead Sciences	$28.75B	$7.55B
ABBV	AbbVie	-	$14.46B

MRK Revenue FAQ

What is Merck’s yearly revenue?

Merck's yearly revenue for 2024 was $64.17B, representing an increase of 6.74% compared to 2023. The company's yearly revenue for 2023 was $60.12B, representing an increase of 1.40% compared to 2022. MRK's yearly revenue for 2022 was $59.28B, representing an increase of 21.72% compared to 2021.

What is Merck’s quarterly revenue?

Merck's quarterly revenue for Q3 2024 was $16.66B, a 3.10% increase from the previous quarter (Q2 2024), and a 4.35% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $16.16B, a 2.42% increase from the previous quarter (Q1 2024), and a 7.46% increase year-over-year (Q2 2023). MRK's quarterly revenue for Q1 2024 was $15.78B, a 7.83% increase from the previous quarter (Q4 2023), and a 8.89% increase year-over-year (Q1 2023).

What is Merck’s revenue growth rate?

Merck's revenue growth rate for the last 3 years (2022-2024) was 8.24%, and for the last 5 years (2020-2024) was 54.55%.

What are Merck’s revenue streams?

Merck's revenue streams in c 24 are Pharmaceutical segment, and Animal Health segment. Pharmaceutical segment generated $57.4B in revenue, accounting 90.71% of the company's total revenue, up 10.37% year-over-year. Animal Health segment generated $5.88B in revenue, accounting 9.29% of the company's total revenue, up 5.89% year-over-year.

What is Merck’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Merck was Pharmaceutical segment. This segment made a revenue of $57.4B, representing 90.71% of the company's total revenue.